# Oracle AI Cloud Growth, ChatGPT Antibiotics and ReWeaver Design Loop
_Oracle on AI cloud buildout concerns, OpenAI on ChatGPT for antibiotics discovery, and ReWeaver AI on why design to code still fails._
**Published:** 2026-09-13
**Source:** https://www.startuphub.ai/ai-news/artificial-intelligence/2026/briefing-bloomberg-technolo-openai-youtube-ai-engineer-2026-09-13-7241
---
Oracle tried to calm fears about AI infrastructure spend while OpenAI researchers showed ChatGPT hunting for antibiotics. And ReWeaver AI founder Jonathan Gordon argued the Figma to code loop still fails in practice.

## Oracle's AI Cloud Growth Eases Buildout Concerns

Bloomberg Technology pressed Oracle on whether AI cloud demand justifies its buildout.

The interview frames recent cloud momentum against questions about capacity, capital spending and customer commitment. The takeaway is whether growth and backlog can keep supporting the scale of data center investment.

[Bloomberg Technology](https://www.youtube.com/watch?v=vgVn3xNJ67g)

## Discovering new antibiotics with ChatGPT

OpenAI highlighted work using ChatGPT to help discover new antibiotics, pointing to model assisted hypothesis generation tied to lab testing. The segment positions language models as research accelerators rather than replacements for experimental validation.

[OpenAI Youtube](https://www.youtube.com/watch?v=0XLGisanEAs)

**The Design Code Roundtrip That Isn't Jonathan Gordon, ReWeaver AI**

Jonathan Gordon says the design to code roundtrip still breaks on the way back. He presents it as a systems problem where edits in code do not cleanly return to design.

[AI Engineer](https://www.youtube.com/watch?v=NW-jwOVr32w)
---
Original analysis from [startuphub.ai](https://www.startuphub.ai), the #1 AI startup directory.